FDA Approved: METHSCOPOLAMINE BROMIDE — Original Application (i3 Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original application for methscopolamine bromide, a generic anticholinergic agent, filed by i3 Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcers
• Gastric Ulcers
• Peptic Ulcer Disease

Drugs mentioned

• Methscopolamine bromide (Methscopolamine bromide)

Snippet

ORIG AP for METHSCOPOLAMINE BROMIDE (METHSCOPOLAMINE BROMIDE)